MOLECULAR BIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2023-09-24 ms6000001823203588 来自山西省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：分子生物学
经验分享：请问大家，投稿多久后会送审？

94 0

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-05-15 ms7000001638461592

Assigned To Editor状态已经5周没变过了正常吗

114 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2019-04-14 阿丘

收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？

201 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-02-01 1480d35dm91暂无昵称

您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表:
收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？

阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？

181 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2018-11-29 阿丘

大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？

241 0

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2018-11-29 阿丘

你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表::
SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表:
投稿方式是给杂志社发送邮件吗?

小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?

262 0

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2018-11-29 阿丘

求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？

243 0

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2018-08-29 1416297786_46750097

molecular biology是英式英语还是美式英语

294 0

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2018-07-20 铭记心中。。

你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表:
前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now.
Unfortunately there is a lot of articles now in editor hands.
The article queue for publication is almost two years.
We recommend to submit you MS in a other journals.
悲伤

gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now.
Unfortunately there is a lot of articles now in editor hands.
The article queue for publication is almost two years.
We recommend to submit you MS in a other journals.
悲伤

263 0

[GetPortalCommentsPageByObjectIdResponse(id=2159448, encodeId=472c21594485f, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：分子生物学 经验分享：请问大家，投稿多久后会送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=637c8738750, createdName=ms6000001823203588, createdTime=Sun Sep 24 15:56:12 CST 2023, time=2023-09-24, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=965872, encodeId=e0b69658e29b, content=Assigned To Editor状态已经5周没变过了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93bd5474469, createdName=ms7000001638461592, createdTime=Sat May 15 17:18:13 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569519, encodeId=2a0f5695198b, content=收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Sun Apr 14 10:58:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584116, encodeId=8a5458411682, content=您好，请问是一直等邮件吗？在哪查看状态呢？阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , beContent=阿丘 2019-04-14 10:58:00 发表: 收到邮件被接收，提交了授权转让协议，下一步呢？再没收到邮件，不用校稿之类的吗？直接等待发表吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac6d5264714, createdName=1480d35dm91暂无昵称, createdTime=Sat Feb 01 00:00:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563764, encodeId=3ced563e644b, content=大神们，投稿方式是有用邮件投稿吗？在哪里查看文章状态呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 10:52:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563769, encodeId=3ae6563e6959, content=你好，是发邮件吗？你后来发的邮件吗？在哪能查看文章进度呢？小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?小辛辛 2016-11-26 11:37:00 发表: 投稿方式是给杂志社发送邮件吗?, beContent=小辛辛 2016-11-26 发表:: SCI(2015)：0.612 投稿方式是给杂志社发送邮件吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563768, encodeId=600c563e6870, content=求助，期刊投稿方式是邮件投稿吗？在哪里能查看文章进度呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eohLylNXf5qWKLKiaTaZxvBicxPKib6EGEkbuchrVnmCd6o1ZMSYYiaribeqCycpmQpPPZ0jYEdMlRMNfQ/132, createdBy=79762215523, createdName=阿丘, createdTime=Thu Nov 29 00:00:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560544, encodeId=1a0e56054486, content=molecular biology是英式英语还是美式英语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2cb2408561, createdName=1416297786_46750097, createdTime=Wed Aug 29 15:35:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559387, encodeId=87cb55938e04, content=你好，版面费多少呢？gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, beContent=gly1334474 2017-02-23 10:22:00 发表: 前面那位仁兄是约稿的，并没有那么快，投稿一周，编辑回信：The Editorial Board can't admit to examination your MS now. Unfortunately there is a lot of articles now in editor hands. The article queue for publication is almost two years. We recommend to submit you MS in a other journals. 悲伤, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542940, encodeId=8791542940cb, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-07-14 weiwei_zhu

反正就这个熊样,也不会有所变化,只要不跌,也就万幸了

264 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务